☰

Fernando F. Blanco, Ph.D. - Publications

Affiliations: 
2012 Biomedical Science University of South Carolina, Columbia, SC 
Area:
Oncology, Molecular Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Blanco FF, Preet R, Aguado A, Vishwakarma V, Stevens LE, Vyas A, Padhye S, Xu L, Weir SJ, Anant S, Meisner-Kober N, Brody JR, Dixon DA. Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. Oncotarget. PMID 27677075 DOI: 10.18632/Oncotarget.12189  0.648
2016 Zhou H, Telonis AG, Jing Y, Xia NL, Biederman L, Jimbo M, Blanco F, Londin E, Brody JR, Rigoutsos I. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Cell Death & Disease. 7: e2294. PMID 27415424 DOI: 10.1038/Cddis.2016.169  0.387
2016 Zhou H, Telonis A, Jing Y, Jimbo M, Blanco F, Londin E, Brody J, Rigoutsos I. Abstract A41: GPRC5A acts as a potent oncogene in pancreatic cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Panca16-A41  0.328
2015 Blanco FF, Jimbo M, Wulfkuhle J, Gallagher I, Deng J, Enyenihi L, Meisner-Kober N, Londin E, Rigoutsos I, Sawicki JA, Risbud MV, Witkiewicz AK, McCue PA, Jiang W, Rui H, et al. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene. PMID 26387536 DOI: 10.1038/Onc.2015.325  0.394
2015 Sobolewski C, Sanduja S, Blanco FF, Hu L, Dixon DA. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5: 2035-55. PMID 26343742 DOI: 10.3390/biom5032035  0.73
2015 Jimbo M, Blanco FF, Huang YH, Telonis AG, Screnci BA, Cosma GL, Alexeev V, Gonye GE, Yeo CJ, Sawicki JA, Winter JM, Brody JR. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget. PMID 26314962 DOI: 10.18632/Oncotarget.4743  0.438
2015 Piasecka-Srader J, Blanco FF, Delman DH, Dixon DA, Geiser JL, Ciereszko RE, Petroff BK. Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biology of Reproduction. 92: 132. PMID 25833159 DOI: 10.1095/Biolreprod.114.126136  0.535
2015 Cozzitorto JA, Jimbo M, Chand S, Blanco F, Lal S, Gilbert M, Winter JM, Gorospe M, Brody JR. Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assays. Methods in Molecular Biology (Clifton, N.J.). 1262: 239-46. PMID 25555585 DOI: 10.1007/978-1-4939-2253-6_14  0.437
2015 Tholey RM, Lal S, Jimbo M, Burkhart RA, Blanco FF, Cozzitorto JA, Eisenberg JD, Jiang W, Iacobuzio-Donahue CA, Witkiewicz AK, Glbert M, Yeo CJ, Brody JR, Sawicki JA, Winter JM. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Molecular Cancer Research : McR. 13: 439-48. PMID 25336517 DOI: 10.1158/1541-7786.Mcr-14-0199  0.318
2015 Jimbo M, Blanco FF, Huang YH, Telonis AG, Screnci BA, Cosma GL, Alexeev V, Gonye GE, Yeo CJ, Sawicki JA, Winter JM, Brody JR. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells Oncotarget. 6: 27312-27331. DOI: 10.18632/oncotarget.4743  0.326
2014 Blanco FF, Sanduja S, Deane NG, Blackshear PJ, Dixon DA. Transforming growth factor β regulates P-body formation through induction of the mRNA decay factor tristetraprolin. Molecular and Cellular Biology. 34: 180-95. PMID 24190969 DOI: 10.1128/Mcb.01020-13  0.677
2013 Dixon DA, Blanco FF, Bruno A, Patrignani P. Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 191: 7-37. PMID 22893198 DOI: 10.1007/978-3-642-30331-9_2  0.698
2013 Blanco FF, Li Y, Meisner-Kober N, Anant S, Dixon DA. Abstract C38: Small molecule targeting of the mRNA stability factor HuR impacts COX-2 expression in colon cancer Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-C38  0.661
2013 Blanco FF, Dixon DA. 680 TGF-β Is a Central Mediator of mRNA Decay Dynamics in Colorectal Cancer Gastroenterology. 144: S-124. DOI: 10.1016/S0016-5085(13)60447-3  0.622
2012 Sanduja S, Blanco FF, Young LE, Kaza V, Dixon DA. The role of tristetraprolin in cancer and inflammation. Frontiers in Bioscience (Landmark Edition). 17: 174-88. PMID 22201737 DOI: 10.2741/3920  0.747
2011 Sanduja S, Blanco FF, Dixon DA. The roles of TTP and BRF proteins in regulated mRNA decay. Wiley Interdisciplinary Reviews. Rna. 2: 42-57. PMID 21278925 DOI: 10.1002/Wrna.28  0.734
2011 Blanco FF, Meisner N, Dixon DA. Abstract 5416: The low-molecular-weight compound MS-444 selectively targets cancer cells via inhibition of the mRNA stability factor HuR Cancer Research. 71: 5416-5416. DOI: 10.1158/1538-7445.Am2011-5416  0.663
2010 Blanco FF, Sanduja S, Young L, Dixon D. Abstract 1225: Regulation of ARE-mediated mRNA decay during colorectal tumorigenesis Cellular and Molecular Biology. 70: 1225-1225. DOI: 10.1158/1538-7445.Am10-1225  0.727
2009 Blanco FF, Young LE, Kanies CL, Beauchamp RD, Dixon DA. T1999 Regulation of Rapid mRNA Decay During Colon Tumorigenesis Gastroenterology. 136: A-617. DOI: 10.1016/S0016-5085(09)62845-6  0.608
Show low-probability matches.